Challenger

Challenger
CME and Preparatory ProductsProgramsWeb ProductsReviewsTech SupportFrequently Asked Questions


Quick Quiz Newsletter
Compliments of Challenger Corporation

Click image to enlarge




Med-Challenger IM
Comprehensive Review and Assessment for Internists


For more information on Challenger's boards preparation, clinical review, and other electronic resources for physicians, visit www.chall.com,
see us in person
at a prominent meeting, or call a Challenger Sales Representative at
1-800-676-0822, ext. 4400.

Try Our Products!
Click Here for a Free Demonstration
.

Issue: May 1, 2008
Case:
Environmental Injuries
Taken from
Med-Challenger IM
All Products | Challenger Corporation
Click Here for a Free Product Demonstration.

Question:

Most spiders are insectivores. While biting they inject neurotoxins (for paralysis) and tissue lysins (to digest the prey's tissues). The volume is usually too small to be hazardous to humans, although it is quite hazardous to insects! In the U.S., most spider bites occur in the southern states during the warmer months. Significantly toxic U.S. species include all of the following EXCEPT:

 
  1. brown recluse (Loxosceles reclusa)
  2. black widow (Latrodectus mactans or hesperus)
  3. redleg spider in Florida (Latrodectus bishopi)
  4. tarantulas

Answer:
Click here for the answer and clinical remediation.


    Win a $500 Educational Grant!
    Write a Question and Answer for ANY Challenger Educational Course. If our Physicians Advisory Board selects YOUR question at their semiannual meeting, you'll receive a $500 educational grant.

    All submissions become the intellectual property of Challenger Corporation but you'll receive author credit for the Question and Answer in our next release. VIEW DETAILS HERE.

    View past newsletters here.


    If you received this newsletter from a friend, Click here to receive your own Quick Quiz Newsletter.

    Compliments of Challenger Corporation
    5100 Poplar Avenue, Ste. 1410
    Memphis, TN 38137


    Copyright (C) Challenger Corporation. All rights reserved.